4.38% -0.042

Intercure Ltd (INCR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Intercure Ltd Stock (INCR) Company Profile

Intercure Ltd

Healthcare (1092)

Prossima data di guadagno

Ultimi documenti SEC

INCR's Discussions on Twitter

Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INCR Intercure Ltd	0.916	54.75M	117.93M	5.00M	-12.91M	0.1314
TAK Takeda Pharmaceutical Co Adr	17.15	53.43B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.10	44.52B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.03	37.52B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.56	32.24B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	535.67	22.46B	3.17B	1.29B	1.01B	27.09

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-05-18	Aggiornamento	Canaccord Genuity	Speculative Buy → Buy

Intercure Ltd Borsa (INCR) Ultime notizie

Intercure Ltd Azioni (INCR) Dati Finanziari

Intercure Ltd (INCR)

Intercure Ltd Stock (INCR) Company Profile

Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Intercure Ltd Borsa (INCR) Ultime notizie

Price to book forward of Intercure Ltd. – NASDAQ:INCR - TradingView

ETFs Investing in InterCure Ltd. Stocks - TradingView

Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into FocusFibonacci Entry Signals - dars.gov.et

InterCure Ltd. Actuals & Estimates (TASE:INCR) - TradingView

Price to earnings forward of InterCure Ltd. – TASE:INCR - TradingView

InterCure Ltd. Actuals & Estimates (BOATS:INCR) - TradingView

Price to sales forward of InterCure Ltd. – TASE:INCR - TradingView

Enterprise value to EBITDA forward of InterCure Ltd. – TASE:INCR - TradingView

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue PictureEnergy Earnings Report - dars.gov.et

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - Sahm

InterCure secures $7.4M funding commitment, may rise to $18.6M - Investing.com UK

InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. - marketscreener.com

InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion - TipRanks

InterCure secures $7.4M funding commitment, may rise to $18.6M By Investing.com - Investing.com South Africa

InterCure (NASDAQ: INCR) lines up NIS 22–54 million private placement funding - Stock Titan

InterCure raises NIS 22M, with room to reach NIS 54M - Stock Titan

InterCure Ltd (INCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

InterCure Ltd (INCR) Institutional Confidence - TradingKey

InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

InterCure Ltd (INCR) Valuation: PE, PB & Fair Value Analysis - TradingKey

InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

InterCure Ltd (INCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

InterCure Ltd (INCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

InterCure Ltd (INCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

InterCure Ltd (INCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

INCR Q2 2023 Earnings: EPS Surpasses Estimates on Operational StrengthEarnings Sentiment Score - Bölüm Sonu Canavarı

InterCure Advances Global Push With Botanico Acquisition Tranche and U.S. Strategy Review - The Globe and Mail

InterCure completes Botanico acquisition and expands into U.S. medical cannabis - MMJDaily

InterCure Initiates Review of US Medical Cannabis Opportunities Following Federal Rescheduling - Cannabis Business Times

InterCure completes first tranche of Botanico acquisition By Investing.com - Investing.com South Africa

InterCure Ltd. Completes First Tranche of Botanico Acquisition to Enhance International Medical Cannabis Platform - Moomoo

InterCure (NASDAQ: INCR) advances Botanico deal and eyes U.S. medical cannabis - Stock Titan

InterCure Initiates Strategic Review of U.S. Medical - GlobeNewswire

U.S. cannabis shift prompts InterCure rethink and new launches in Germany - Stock Titan

InterCure Ltd. completed the acquisition of 50% stake in Botanico Ltd. - marketscreener.com

Intercure Ltd. (INCR) Holds Near Support as Modest Gains Signal Stabilization AttemptRevenue Weighted - newsline.com

INCR Q2 2023 Earnings: EPS Surges Past Estimates by Nearly 29%, Yet Stock Sheds ValueSegment Revenue Breakdown - newsline.com

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.68% Amidst Revenue Uncertainty - dars.gov.et

INCR Q2 2023 Earnings: EPS Surpasses Estimates by 28.7%, Driving Stock HigherPositive Surprise Momentum - newsline.com

INCR Q2 2023 Earnings: EPS Surges Past Estimates, Stock Declines Amid Broader Market HeadwindsRevenue Surprise History - dars.gov.et

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beat Drives 12.15% Stock SurgeEnergy Earnings Report - newsline.com

INCR Q2 2023 Earnings: EPS Surpasses Estimates by 28.68%Debt Analysis Report - The Legal Advocate

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Surges Past Estimates, Stock RalliesSurprise Factor Analysis - The Legal Advocate

Intercure Ltd. Shares Surge Over 15% as Cannabis Sector Sees Renewed InterestThrowback Trade - newsline.com

INCR Q2 2023 Earnings: EPS Surges Past Estimates as Profitability StrengthensProfit Warning Alert - The Legal Advocate

Intercure Ltd. (INCR) Rallies 5.57% as It Approaches Key Resistance LevelRSI Oversold Picks - The Legal Advocate

INCR Q2 2023 Earnings: Strong EPS Beat Highlights Operational EfficiencyEarnings Analysis - thelegaladvocate.com

INCRIntercure Ltd Stock Price and Quote - Finviz

Intercure Ltd. (INCR) Rallies 4.8%: Testing Key Resistance at $0.97Risk Reward Setups - newsline.com

INCR Q2 2023 Earnings: EPS Beat Surprises by 28.7% Despite Revenue UncertaintyShare Repurchase Impact - dars.gov.et

INCR Q2 2023 Earnings: EPS Surges Past Estimates as Company Delivers Strong Operational ResultsEarnings Trend Analysis - Newser

Intercure Ltd Azioni (INCR) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a INCR